Sarcopenia in the Acute Stroke (SARCOSTROKE)
Follow up of Strength and Body Composition With Impedancemeter Device During the First 10 Days After Acute Stroke.
Sponsor: Centre Hospitalier Régional d'Orléans
Terminated
Departure of the principal investigator
Other terminated trials from Centre Hospitalier Régional d'Orléans
- Hypovolemia · Phase NA · May 2024
- COVID-19 · Phase NA · Mar 2023
- Parkinson Disease · Phase NA · Dec 2022
- Muscle Weakness · Phase NA · Dec 2021
- Spouse Abuse · Jul 2021
See all terminations from Centre Hospitalier Régional d'Orléans
Other Stroke, Acute trials with similar outcome
Listed as NCT06603701, this NA trial focuses on Stroke, Acute and remains terminated or withdrawn. Sponsored by Centre Hospitalier Régional d'Orléans, it has been updated 3 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
3 versions recorded-
Jan 2026 — Present [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Sep 2025 — Jan 2026 [monthly]
Recruiting NA
-
Oct 2024 — Sep 2025 [monthly]
Recruiting NA
First recorded
Jun 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Régional d'Orléans
For direct contact, visit the study record on ClinicalTrials.gov .